AHG
Akso Health GroupNASDAQFinancial Services$2.22-4.31%ClosedMarket Cap: $210.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.77
P/S
27.17
EV/EBITDA
-161.74
DCF Value
$-11.56
FCF Yield
2.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-6.0%
Operating Margin
-2113.4%
Net Margin
-1713.4%
ROE
-67.6%
ROA
-63.4%
ROIC
-82.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.9M | -6.0% | $-82.9M | $-67.2M | $-0.20 | — |
| FY 2025 | $14.8M | -1.9% | $-166.3M | $-135.0M | $-0.48 | — |
| Q3 2025 | $3.9M | -6.0% | $-82.9M | $-67.2M | $-0.20 | — |
| Q2 2025 | $3.5M | 2.8% | $-270.4K | $-293.3K | $-0.00 | — |
| Q1 2025 | $3.5M | 2.8% | $-270.4K | $-293.3K | $-0.00 | — |
| Q4 2024 | $760.4K | 5.5% | $-3.2M | $-3.0M | $-0.13 | — |
| FY 2024 | $2.4M | 5.1% | $-8.6M | $-9.5M | $-0.39 | — |
| Q3 2024 | $760.4K | 5.5% | $-3.2M | $-3.0M | $-0.13 | — |
| Q2 2024 | $446.8K | 4.3% | $-1.2M | $-1.5M | $-0.20 | — |
| Q1 2024 | $446.8K | 4.3% | $-1.2M | $-1.5M | $-0.20 | — |
| Q4 2023 | $662.2K | 10.8% | $-7.0M | $-7.4M | $-0.96 | — |
| FY 2023 | $13.2M | 9.6% | $-14.3M | $-1.4M | $-0.06 | — |